Alexandre Loiseau - Mauna Kea CEO, Director
| MKEAF Stock | USD 0.37 0.00 0.00% |
CEO
Mr. Alexandre Loiseau has served as a Chief Executive Officer and Director at Mauna Kea Technologies SA since May 2000. He started his career at the National Center for Space Studies in Toulouse and at the Paris Observatory then joined NASA Jet Propulsion Laboratory in Pasadena California as a research scientist. He is a graduate of Ecole Polytechnique and holds a Ph.D. in Astrophysics and Optical Instrumentation. since 2000.
| Tenure | 24 years |
| Professional Marks | Ph.D |
| Phone | 33 1 48 24 03 45 |
| Web | https://www.maunakeatech.com |
Mauna Kea Management Efficiency
The company has return on total asset (ROA) of (0.4393) % which means that it has lost $0.4393 on every $100 spent on assets. This is way below average. Mauna Kea's management efficiency ratios could be used to measure how well Mauna Kea manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 12 records | CEO Age | ||
| Roland Diggelmann | Smith Nephew SNATS | 53 | |
| Steven Williamson | Pulmonx Corp | 51 | |
| Mark Throdahl | Orthopediatrics Corp | 73 | |
| Vafa Jamali | ZimVie Inc | 54 | |
| Maher Masoud | MaxCyte | 49 | |
| Walter Rosebrough | STERIS plc | 70 | |
| Robert Ford | Abbott Laboratories | 50 | |
| Deepak Nath | Smith Nephew SNATS | 52 | |
| Massimo Calafiore | Orthofix Medical | 52 | |
| Masoud Toloue | Quanterix Corp | 43 | |
| Glendon French | Pulmonx Corp | 62 | |
| Reza Zadno | Procept Biorobotics Corp | 69 | |
Management Performance
| Return On Asset | -0.44 |
Mauna Kea Technologies Leadership Team
Elected by the shareholders, the Mauna Kea's board of directors comprises two types of representatives: Mauna Kea inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mauna. The board's role is to monitor Mauna Kea's management team and ensure that shareholders' interests are well served. Mauna Kea's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mauna Kea's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daryl Donatelli, VP Sales | ||
| Alexandre Loiseau, CEO, Director | ||
| Frederic Banegas, Chief Officer | ||
| Nicolas Bouvier, HR Director | ||
| Aline Criton, Regulatory and Clinical Affairs and Scientific Communication Director | ||
| Bruno Villaret, General Manager for Asia Pacific | ||
| John Soto, Chief Officer | ||
| Franois Lacombe, Chief Officer |
Mauna Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Mauna Kea a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.44 | |||
| Profit Margin | (1.55) % | |||
| Operating Margin | (1.39) % | |||
| Current Valuation | 44.78 M | |||
| Shares Outstanding | 44.52 M | |||
| Shares Owned By Insiders | 1.15 % | |||
| Shares Owned By Institutions | 24.44 % | |||
| Price To Earning | (7.09) X | |||
| Price To Book | 123.19 X | |||
| Price To Sales | 2.92 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Mauna Pink Sheet
Mauna Kea financial ratios help investors to determine whether Mauna Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mauna with respect to the benefits of owning Mauna Kea security.